Suppr超能文献

一种具有强效、靶向和选择性抗疟原虫活性的泛硫乙胺酶抗性泛酰乙胺。

A pantetheinase-resistant pantothenamide with potent, on-target, and selective antiplasmodial activity.

作者信息

Macuamule Cristiano J, Tjhin Erick T, Jana Collins E, Barnard Leanne, Koekemoer Lizbé, de Villiers Marianne, Saliba Kevin J, Strauss Erick

机构信息

Department of Biochemistry, Stellenbosch University, Stellenbosch, South Africa.

Research School of Biology, College of Medicine, Biology, and Environment, The Australian National University, Canberra, ACT, Australia.

出版信息

Antimicrob Agents Chemother. 2015;59(6):3666-8. doi: 10.1128/AAC.04970-14. Epub 2015 Apr 6.

Abstract

Pantothenamides inhibit blood-stage Plasmodium falciparum with potencies (50% inhibitory concentration [IC50], ∼20 nM) similar to that of chloroquine. They target processes dependent on pantothenate, a precursor of the essential metabolic cofactor coenzyme A. However, their antiplasmodial activity is reduced due to degradation by serum pantetheinase. Minor modification of the pantothenamide structure led to the identification of α-methyl-N-phenethyl-pantothenamide, a pantothenamide resistant to degradation, with excellent antiplasmodial activity (IC50, 52 ± 6 nM), target specificity, and low toxicity.

摘要

泛硫乙胺抑制恶性疟原虫血液期的效力(50%抑制浓度[IC50],约20 nM)与氯喹相似。它们作用于依赖泛酸盐(必需代谢辅因子辅酶A的前体)的过程。然而,由于血清泛肽酶的降解作用,它们的抗疟原虫活性降低。对泛硫乙胺结构进行微小修饰后,鉴定出α-甲基-N-苯乙基-泛硫乙胺,这是一种抗降解的泛硫乙胺,具有出色的抗疟原虫活性(IC50,52±6 nM)、靶标特异性和低毒性。

相似文献

引用本文的文献

1
Highly Regioselective Protecting-Group-Free Synthesis of the Antimalarial Drug MMV693183.抗疟药物MMV693183的高区域选择性无保护基合成
Org Process Res Dev. 2023 Dec 9;28(1):273-280. doi: 10.1021/acs.oprd.3c00353. eCollection 2024 Jan 19.
4
A novel heteromeric pantothenate kinase complex in apicomplexan parasites.一种新型异源泛酸激酶复合物在顶复门寄生虫中。
PLoS Pathog. 2021 Jul 29;17(7):e1009797. doi: 10.1371/journal.ppat.1009797. eCollection 2021 Jul.
9
Modular Enzymatic Cascade Synthesis of Vitamin B and Its Derivatives.维生素 B 及其衍生物的模块化酶级联合成。
Chemistry. 2018 Nov 27;24(66):17434-17438. doi: 10.1002/chem.201804151. Epub 2018 Oct 30.

本文引用的文献

8
Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.抗癌组蛋白去乙酰化酶抑制剂 SB939 的抗疟活性。
Antimicrob Agents Chemother. 2012 Jul;56(7):3849-56. doi: 10.1128/AAC.00030-12. Epub 2012 Apr 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验